InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,267.84
(
-0.74%
)
US TECH 100
18,152.00
(
-0.42%
)
Dow Jones
39,065.26
(
-1.53%
)
Brent Oil
81.09
(
-0.28%
)
Bitcoin
67,738.80
(
-0.27%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

micanwait

Send PM Follow Ignore
Followers 6
Posts 718
Boards Moderated 0
Alias Born 06/22/2011

micanwait

Re: biotech_researcher post# 50232

Sunday, 06/15/2014 9:56:58 AM

Sunday, June 15, 2014 9:56:58 AM

Post# of 80490
Indeed, the trial design would have been different. I wonder if this rises to the level of a legal cause of action for Ariad as well as Ariad's patients in their trials.

And if Gleevec has to be re-labeled, what might that mean for pona as 1st line?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up